Citations

Showing 10 of 108119 citations.

Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease
McNicholas, Bairbre , Yoshida, Kotaro , Martin, William P. , Sharma, Ayush , Kamath, Patrick S. , Edwards, Marie E., Kremers, Walter K. , Chari, Suresh T. , Torres, Vicente E. , Harris, Peter C. , Takahashi, Naoki , Hogan, Marie C. , Harris, Peter C , Torres, Vicente E , Kremers, Walter K , Takahashi, Naoki , Hogan, Marie C , Chari, Suresh T

Mayo Clinic

Pancreas | May 6, 2019 | Volume: 48 | Issue: 5 | Pages: 698-705

10.1097/mpa.0000000000001306 | PMID 31091218 Get It

Objectives Pancreatic lesions in autosomal dominant polycystic kidney disease (ADPKD) are primarily cysts. They are increasingly recognized, with isolated reports of intraductal papillary mucinous neoplasia (IPMN). Methods Retrospective study to determine prevalence, number, size, and location of pancreatic abnormalities using abdominal magnetic resonance imaging (MRI) of genotyped ADPKD patients (seen February 1998 to October 2013) and compared with age- and sex-matched non-ADPKD controls. We evaluated presentation, investigation, and management of all IPMNs among individuals with ADPKD (January 1997 to December 2016). Results Abdominal MRIs were examined for 271 genotyped ADPKD patients. A pancreatic cyst lesion (PCL) was detected in 52 patients (19%; 95% confidence interval, 15%–23%). Thirty-seven (71%) had a solitary PCL; 15 (28%) had multiple. Pancreatic cyst lesion prevalence did not differ by genotype. Intraductal papillary mucinous neoplasia was detected in 1% of ADPKD cases. Among 12 IPMN patients (7 branch duct; 5 main duct or mixed type) monitored for about 140 months, 2 with main duct IPMNs required Whipple resection, and 1 patient died of complications from small-bowel obstruction after declining surgical intervention. Conclusions With MRI, PCLs were detected in 19% and IPMNs in 1% of 271 ADPKD patients with proven mutations, without difference across genotypes. Pancreatic cyst lesions were asymptomatic and remained stable in size.
A New Lateral Wall Electrode: Evaluation of Surgical Handling, Radiographic Placement, and Histological Appraisal of Insertion Trauma
Kim, Ana H. , Driscoll, Colin L. W., Cullen, Robert D., Rebscher, Stephen J., Rivas, Alejandro , Yawn, Robert J. , Isaacson, Brandon

Mayo Clinic

Otology & Neurotology | May 6, 2019 | Volume: 40 | Issue: 5S | Pages: S23-S28

10.1097/mao.0000000000002210 | PMID 31225819 Get It

Objective: To describe histologic and radiographic findings associated with insertion of a new lateral wall electrode in human temporal bones, as well as quantify the ease of insertion as characterized by multiple cochlear implant surgeons. Setting: Multi-institutional cadaveric study. Methods: The Slim J electrode was inserted in cadaveric temporal bones via a standard mastoidectomy and facial recess approach. Insertion was performed by five cochlear implant surgeons with no previous experience with the Slim J electrode array. Electrode array insertion was performed via a round window, an extended round window, or a cochleostomy approach. Intracochlear trauma, and angular insertion depth was assessed histologically and radiologically, respectively, after placement of the Slim J electrode array. Results: Scala tympani insertion was accomplished in all 40 specimens. Thirty-eight specimens (95%) showed minimal trauma (Esrhaghi grade 0 or 1). One patient had rupture of basilar membrane (grade 2 trauma) at 380 degrees. One patient had grade 4 trauma with scalar translocation beginning at 210 degrees. The mean angular insertion depth was 416.4 degrees (range: 338.7–509.2 degrees, SD 44 degrees). Surgical handling was described as easy in 38 cases (95%). Conclusion: In a human cadaveric model the lateral wall Slim J electrode produced minimal intracochlear trauma that was positioned completely within the scala tympani in 97.5% of cases.
Evaluation of the Patient with Incidental Left Ventricular Hypertrophy on Echocardiography
Newman, Darrell B. , Bois, John P. , Geske, Jeffrey B. , Geske, Jeffrey B

Mayo Clinic

Cardiovascular Innovations and Applications | May 6, 2019 | Volume: 4 | Issue: 1 | Pages: No page available

10.15212/cvia.2019.0011 Get It

Left ventricular hypertrophy (LVH), or an increase in cardiac mass, usually reflects pathologic adaptation to chronic pressure or volume loads. Physiologic adaptation in athletes as well as genetic, metabolic, and infiltrative disorders may also result in increased cardiac mass. Given vast differences in prognosis and therapeutic options associated with different underlying conditions, the evaluation of patients with LVH necessitates a modern, comprehensive evaluation incorporating multimodality imaging. Herein we present a systematic approach to patients with incidental LVH.
Polytrauma Transitional Rehabilitation in the Veterans Administration: Implementing the Principles of Person-Centered, Participation-Oriented Rehabilitation
Malec, James F.

Mayo Clinic

Journal of Head Trauma Rehabilitation | May 6, 2019 | Volume: 34 | Issue: 3 | Pages: 135-140

10.1097/htr.0000000000000456 | PMID 31058755 Get It

Objective: To review principles of person-centered, participation-oriented (PCPO) rehabilitation and introduce their implementation in Veterans Administration (VA) Polytrauma Transitional Rehabilitation Programs (PTRPs). Background: Post–hospital rehabilitation for individuals with acquired brain injury (ABI) has evolved toward PCPO rehabilitation, an approach that makes participation goals identified by the person served and his or her significant others the primary focus of rehabilitation. Goals to reduce impairments and increase activities contribute to the achievement of primary participation goals. Research, primarily in the nonveteran population, confirms the effectiveness of PCPO rehabilitation. Overview: In the civilian sector, PCPO programs are generally provided locally or regionally in outpatient or community settings to individuals with moderate-severe ABI associated with other traumatic injuries and comorbidities. Because of the geographical dispersion of veterans, the VA provides these services in residential centers serving larger geographical areas. The group of veterans served more often has sustained milder traumatic ABI associated with neuropsychiatric comorbidities, particularly posttraumatic stress disorder and depression. Measuring progress and outcome is important to establish a feedback loop for process improvement. VA PTRPs use state-of-the-science standardized outcome measures and methods for identifying successful cases, that is, the minimal clinically important difference. Vocational reintegration is an important element of PCPO rehabilitation. Articles in this special section detail the development and effectiveness of PTRPs.
A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation
Hu, Yiqun , Datto, Catherine , Creanga, Dana, Camilleri, Michael , Brenner, Darren M.

Mayo Clinic

American Journal of Gastroenterology | May 6, 2019 | Volume: 114 | Issue: 6 | Pages: 954-963

10.14309/ajg.0000000000000229 | PMID 31058652 Get It

Objectives: To determine patient preference for treating opioid-induced constipation (OIC) using naloxegol or polyethylene glycol (PEG) 3350 in patients receiving opioids for noncancer pain. Methods: This crossover study included two 2-week active treatment periods, each preceded by a 1-week washout period (NCT03060512). Individuals with baseline Bowel Function Index scores ≥30 were randomized to 1 of 2 treatment sequences (naloxegol/PEG 3350 or PEG 3350/naloxegol). Patient preference (primary end point) was measured at the end of the second treatment period. Results: Of 276 patients randomized, 246 completed both treatment periods and reported preference (per protocol). Similar proportions of patients reported overall preference for naloxegol (50.4%) or PEG 3350 (48.0%; P = 0.92); 1.6% reported no preference. Medication characteristics influencing preference were similar for both treatments, except convenience and working quickly, which were strong influences of preference for higher proportions of patients preferring naloxegol (69.9% and 39.0%, respectively) vs those preferring PEG 3350 (29.9% and 27.4%, respectively). Patients aged <50 years or receiving laxatives within the previous 2 weeks generally preferred naloxegol. Changes from baseline in overall Bowel Function Index and Patient Global Impression of Change scores were similar between treatments, but analyses according to treatment preference revealed clinical improvement aligned with reported preference. Safety profiles were generally consistent with known medication profiles. Conclusions: Almost equal proportions of patients with OIC reported similar preference for daily naloxegol or PEG 3350 treatment, and their preference was generally supported by clinically relevant and measurable improvements in OIC symptoms.
Discontinuation of Levonorgestrel Intrauterine System (LNGIUS) Versus Low Dose LNGIUS (LD-LNGIUS) [4H]
Weaver, Amy, Casey, Petra M., Cope, Adela G.

Mayo Clinic

Obstetrics & Gynecology | May 6, 2019 | Volume: 133 | Issue: 1 | Pages: 85S-85S

10.1097/01.aog.0000558743.96229.50 Get It

INTRODUCTION: Rates of long acting reversible contraception (LARC) use, including LNGIUS and LD-LNGIUS the United States are increasing. The aim of this study was to compare rates of and reasons for discontinuation of these two LARC. METHODS: Following IRB approval, premenopausal women 13-55 years old undergoing LD-LNGIUS (13.5 mg) insertion for contraception at Mayo Clinic Rochester from 1/1/2013 to 12/31/2015 were identified (n=82). A random sample of 328 women meeting the same criteria with LNGIUS insertion was identified. The cumulative incidence of discontinuation for symptom-related complaints was compared between groups after taking into account discontinuation for other reasons as a competing risk. RESULTS: Compared to those with LNGIUS, women with LD-LNGIUS were younger (mean age, 25.9 vs. 30.3 years), more likely to be nulliparous (86.6% vs. 28.0%), less likely to have previously used LARC (13.4% vs. 35.1%), and had lower BMI (mean, 25.2 vs. 27.0 kg/m 2 ). In women with subsequent follow-up, 57.3% (43/75) of the women with LD-LNGIUS expressed a symptom concern compared to 60.9% (171/281) of the women with LNGIUS. The cumulative incidence of discontinuation for symptom-related complaints by 2 years was higher in the LD-LNGIUS group, with rates of 20.0% vs. 13.8% based on patients with follow-up and 23.4% vs.12.8% based on a subset of 58+58 women matched on age, race, gravidity, and insertion year. CONCLUSION: Women with LD-LNGIUS are less likely to express symptom concerns than women with LNGIUS, but more likely to discontinue for symptom-related complaints. These findings may inform counseling of women with hormonal intrauterine contraception placement.
Timing of Pregnancy After Ovarian Hyperstimulation Syndrome and Pregnancy-Related Outcomes [35T]
Sangtani, Ajleeta , Ismail, Maryama, Khan, Zaraq

Mayo Clinic

Obstetrics & Gynecology | May 6, 2019 | Volume: 133 | Issue: 1 | Pages: 222S-222S

10.1097/01.aog.0000559137.28848.a9 Get It

INTRODUCTION: The incidence of ovarian hyperstimulation syndrome (OHSS) after assisted reproduction is approximately 3%. The outcomes of pregnancy in immediate versus delayed pregnancy has not been previously studied. METHODS: A retrospective cohort study was conducted using the Rochester Epidemiology Project Database. Residents of Olmsted County and the surrounding 9 counties with OHSS were identified between 1995 and 2017. Patients were included if they had a pregnancy lasting ≥20 weeks gestation after the diagnosis of OHSS. Background data and pregnancy outcomes were collected. Data were then analyzed using a combination of t-test and Chi squared test. Women with OHSS and same cycle pregnancy were compared to those with subsequent cycle pregnancy. RESULTS: 85 women with OHSS were analyzed, 47 with same-cycle pregnancies and 38 with subsequent cycle pregnancies. Background data did not differ between the two groups for infertility cause, body mass index, gestational age, parity, or number of embryos transferred. OHSS treatment modalities (paracentesis, thoracentesis, hospitalization and medical treatment) did not differ between groups. Patients with same-cycle pregnancies had neonates delivered at 35.6 weeks compared to 38.3 weeks with delayed pregnancies (p=0.0006). Patients with same cycle pregnancies also had lower birth weights compared to patients with delayed pregnancies (3201 g v 2628 g, p=0.003). Incidence of hypertensive disorders, diabetes, placental abruption, thromboembolism, intrauterine fetal death, intrauterine growth restriction, and 1 and 5 minute Apgar scores did not differ between the two groups. CONCLUSION: The data gives new insight into the risk of same-cycle pregnancies in patients with OHSS. Larger studies are needed to confirm the data.
Effect of Hypertensive Disorders of Pregnancy on Clinical Outcomes in Peripartum Cardiomyopathy [39I]
Sangtani, Ajleeta , Alrahmani, Layan , Parikh, Pavan

Mayo Clinic

Obstetrics & Gynecology | May 6, 2019 | Volume: 133 | Issue: 1 | Pages: 105S-105S

10.1097/01.aog.0000558816.32494.40 Get It

INTRODUCTION: The influence of concurrent hypertensive disorders of pregnancy (HDP) on clinical outcomes of patients with peripartum cardiomyopathy (PPCM) remains incompletely characterized, with authors describing harmful and beneficial relationships with regards to maternal mortality or requirement for cardiac transplantation. METHODS: Ovid Medline, EMBASE, CENTRAL and Scopus were searched for combinations of the following terminology: hypertension, preeclampsia, cardiomyopathy, peripartum, postpartum or puerperium. Eligibility criteria included all articles addressing mortality rates of PPCM with and without HDP using a combination of the European Society of Cardiology 2010 and the National Heart Lung Blood Institute 2000 diagnostic criteria. Two independent reviewers analyzed abstracts and article text to determine eligibility and risk of bias. Risk of bias was determined using the Newcastle-Ottawa scale and a Peto fixed effects model was used to combine odds ratios in a meta-analytic fashion due to the relatively rare frequency of these events. RESULTS: 1838 articles were identified using the search strategy; 148 full text articles were reviewed for eligibility, with 10 observational studies meeting criteria. There was substantial agreement between the two raters for selection (K: 0.799) and for risk of bias (K: 0.851). An overall protective effect was identified [0.565 (95% CI 0.327, 0.974)], with a low degree of heterogeneity (I2 17.66%). No significant differences were found between subgroups-chronic hypertension, access to social medicine, high-income countries and post-diagnosis duration of care greater than 12 months. CONCLUSION: Although the strength of association is weak, concurrent HDP appears to be protective against mortality and need for cardiac transplantation in PPCM.
Summary of the AAPM task group 248 report: Interoperability assessment for the commissioning of medical imaging acquisition systems
Walz‐Flannigan, Alisa , Weiser, John C., Goode, Allen R. , Junck, Kevin L., Tarbox, Lawrence , Dave, Jaydev K. , Clunie, David , Langer, Steve G., McColl, Roderick W.

Mayo Clinic

Medical Physics | May 6, 2019 | Volume: 46 | Issue: 7 | Pages: No page available

10.1002/mp.13571 | PMID 31055845 Get It

PurposeWe summarize the AAPM TG248 Task Group report on interoperability assessment for the commissioning of medical imaging acquisition systems in order to bring needed attention to the value and role of quality assurance testing throughout the imaging chain.MethodsTo guide the clinical physicist involved in commissioning of imaging systems, we describe a framework and tools for incorporating interoperability assessment into imaging equipment commissioning.ResultsWhile equipment commissioning may coincide with equipment acceptance testing, its scope may extend beyond validation of product or purchase specifications. Equipment commissioning is meant to provide assurance that a system is ready for clinical use, and system interoperability plays an essential role in the clinical use of an imaging system.ConclusionThe functionality of a diagnostic imaging system extends beyond the acquisition console and depends on interoperability with a host of other systems such as the Radiology Information System, a Picture Archive and Communication System, post‐processing software, treatment planning software, and clinical viewers.
Using Quality Improvement to Increase the Awareness of Obesity Among Endometrial Cancer Patients [38R]
Shafa, Anousheh, Bird, Megan , Torres, Diogo , Mundi, Manpreet S. , Langstraat, Carrie , Kumar, Amanika

Mayo Clinic

Obstetrics & Gynecology | May 6, 2019 | Volume: 133 | Issue: 1 | Pages: 201S-201S

10.1097/01.aog.0000559155.06870.33 Get It

INTRODUCTION: Obesity is associated with endometrial cancer (EC); however, most patients are unaware of this association and the long-term consequences of their elevated body mass index (BMI). Our objectives were to increase both patient awareness of this association and referral rates to our weight loss clinic using quality improvement (QI) methodology. METHODS: A multidisciplinary team used QI methods to create a multi-pronged toolkit to improve obesity education in patients < 80 years old with a BMI ≥30 mg/kg2 and diagnosis of grade 1-2, stage I EC. Gynecologic oncology and bariatric surgery providers, endocrinologists, nutritionists, and psychologists collaboratively implemented the toolkit comprised of provider communication workshops, patient education resources, and dictation templates. A historic cohort from (July through December 2015) was compared to a post-intervention cohort (July through December 2017). Clinical characteristics, documented conversations, and referrals to the weight loss clinic were abstracted. Data for the two cohorts were compared using Chi-squared test, Fisher exact test, and Student t-test. RESULTS: The historic cohort had 54 patients and the post-intervention cohort had 53 patients. Clinical characteristics were balanced between groups. Conversations about obesity increased from 11.1% (6/54) to 79.2% (42/53) after toolkit implementation (P<.001). Referral rates to the weight loss clinic also increased from 3.7% (2/54) to 25.9% (14/53) (P<.005). No clinical characteristics, including age, BMI, or pre-operative diagnosis, were associated with documented conversations or referrals (P=1.0). CONCLUSION: A multidisciplinary quality improvement project can be used to increase discussion about obesity and referral to a weight loss clinic in patients with low-risk EC.